FIVE PRIME THERAPEUTICS INC Business Finance Contracts & Agreements

21 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement between Five Prime Therapeutics, Inc. and Cowen and Company, LLC and SVB Leerink LLC (November 12, 2020)
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2020
Sales Agreement between Five Prime Therapeutics, Inc. and Cowen and Company, LLC for Up to $75,000,000 of Common Stock
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2020
Waiver of Executive Severance Benefits Agreement between Five Prime Therapeutics, Inc. and William R. Ringo
Waiver Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 – FPRX
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2020
Amendment to Stock Option Agreements between Five Prime Therapeutics, Inc. and Marc Belsky
Modification Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2018
Underwriting Agreement between Five Prime Therapeutics, Inc. and Underwriters (Goldman Sachs, J.P. Morgan, Leerink Partners) for Common Stock Offering
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2018
Underwriting Agreement for 3,410,000 Shares of Common Stock of Five Prime Therapeutics, Inc. with Citigroup, Leerink, and Wells Fargo
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2015
Stock Purchase Agreement between Bristol-Myers Squibb Company and Five Prime Therapeutics, Inc. dated March 14, 2014
Purchase Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Underwriting Agreement between Five Prime Therapeutics, Inc. and Jefferies LLC, BMO Capital Markets Corp., and Wells Fargo Securities, LLC
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Underwriting Agreement between Five Prime Therapeutics, Inc. and Jefferies LLC, BMO Capital Markets Corp., and Wells Fargo Securities, LLC (2013)
Underwriting Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Five Prime Therapeutics, Inc. Stock Option Grant Notice to Aron Knickerbocker (2002 Equity Incentive Plan)
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Amendment No. 1 to Respiratory Diseases Research Collaboration and License Agreement between Glaxo Group Limited and Five Prime Therapeutics, Inc.
Modification Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Five Prime Therapeutics, Inc. 2010 Equity Incentive Plan Option Agreement
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. 2010 Equity Incentive Plan
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Five Prime Therapeutics, Inc. 2002 Equity Incentive Plan Stock Option Agreement
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Five Prime Therapeutics, Inc. 2002 Equity Incentive Plan (as Amended and Restated)
Equity Distribution Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Warrant Agreement to Purchase Series A Preferred Stock between Five Prime Therapeutics, Inc. and General Electric Capital Corporation (January 26, 2004)
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Five Prime Therapeutics, Inc. Series A Preferred Stock Warrant Agreement
Warrant Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013
Common Stock Certificate for Five Prime Therapeutics, Inc.
Stock Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Amendment to Stock Option Agreement between Five Prime Therapeutics, Inc. and Aron Knickerbocker (March 15, 2011)
Stock Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2013
Seventh Amended and Restated Investor Rights Agreement among Five Prime Therapeutics, Inc. and Investors (April 16, 2012)
Investor Rights Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2013